|  Help  |  About  |  Contact Us

Publication : Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

First Author  Xiao C Year  2008
Journal  Nat Immunol Volume  9
Issue  4 Pages  405-14
PubMed ID  18327259 Mgi Jnum  J:133215
Mgi Id  MGI:3778108 Doi  10.1038/ni1575
Citation  Xiao C, et al. (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405-14
abstractText  The genomic region encoding the miR-17-92 microRNA (miRNA) cluster is often amplified in lymphoma and other cancers, and cancer cells carrying this amplification have higher expression of miRNA in this cluster. Retroviral expression of miR-17-92 accelerates c-Myc-induced lymphoma development, but precisely how higher expression of miR-17-92 promotes lymphomagenesis remains unclear. Here we generated mice with higher expression of miR-17-92 in lymphocytes. These mice developed lymphoproliferative disease and autoimmunity and died prematurely. Lymphocytes from these mice showed more proliferation and less activation-induced cell death. The miR-17-92 miRNA suppressed expression of the tumor suppressor PTEN and the proapoptotic protein Bim. This mechanism probably contributed to the lymphoproliferative disease and autoimmunity of miR-17-92-transgenic mice and contributes to lymphoma development in patients with amplifications of the miR-17-92 coding region.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

18 Bio Entities

Trail: Publication

0 Expression